Bisphosphonates for therapy | Paget’s disease

Bisphosphonates for therapy

The following bisphosphonates are currently approved for the treatment of Paget’s disease: The choice of the form of therapy, and thus in particular the drug therapy of Paget’s disease, must always be determined individually with regard to the substances administered, the dosage and the duration of the therapy. Combinations of the various therapeutic measures are also conceivable.

  • Etidronate 400 mgDaily oral 6 months
  • Pamidronate 30 mgweek i. v. over 4 hours 6 weeks
  • Tiludronate 400 mg/day oral 3 months
  • Risedronate 30 mg/day oral 2 months
  • Zoledronic acid 5 mg short infusion 15 minutes once

All articles in this series:

  1. Paget’s disease
  2. Symptoms
  3. General information
  4. Bone biopsy
  5. Bisphosphonates for therapy